Home › Trials › NCT07626151
Clinical trial Recruiting at 1 site Interventional Ages 40 to 80 Men only

Electric cardiometry-guided fluid therapy during robotic prostatectomy

Official title: Effect Of Standard Versus Restricted Fluid Therapy Guided By Electric Cardiometry On Tissue Perfuison In Robotic Prostaectomy: A Randomized Controlled Study

Run by Cairo University · NCT07626151 · Data updated 2026-11-12

This study tests whether using an electrical cardiometry device to guide fluid administration during robotic prostatectomy improves patient care compared with a standard fluid approach.

Quick facts

Study typeInterventional
Ages40 Years to 80 Years
SexMen only
Enrollment90 (estimated)
SponsorCairo University
Academic / other
Locations1 site (Cairo)
StatusRecruiting
StartedJune 5, 2026
Main results expectedDecember 2026
Study endsDecember 2026
Registry record updatedJune 8, 2026
Trial IDNCT07626151 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Male patients undergoing robotic-assisted prostatectomy with ASA physical status I–III.

Probably not a fit

Patients with ASA IV or higher, BMI above 40, severe renal disease, prior renal surgery, or decompensated cardiac disease may not benefit and could be at higher risk.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional trial compares two fluid-management strategies during robotic-assisted prostatectomy: liberal versus restricted fluid administration guided by electrical cardiometry-derived measurements. Electrical cardiometry is used to estimate stroke volume variation and guide intraoperative fluid decisions. The goal is to optimize tissue perfusion while minimizing risks from both fluid overload and under-resuscitation. The study leverages a non-invasive monitoring method common in perioperative care to personalize fluid therapy. Conducted at Cairo University Hospitals under a single lead sponsor, it targets adult male patients undergoing this surgery and excludes those with high surgical risk or significant renal or cardiac disease.

Why it matters

Potential benefit: If successful, using electrical cardiometry to tailor fluid therapy could reduce complications related to fluid imbalance and improve recovery after robotic prostatectomy.

How similar studies have gone: Previous studies using dynamic hemodynamic monitoring to guide fluid therapy have shown mixed but encouraging results; this trial applies the approach specifically to robotic prostatectomy.

Who can join: the full rules

Show full inclusion / exclusion criteria 
Inclusion Criteria:

* Male patient undergoing robotic assisted prostatectomy
* ASA I-III

Exclusion Criteria:

* ASA score more than III
* BMI more than 40
* Severe renal disease (GFR between 15 and 29)
* Previous renal surgery.
* Decompensated cardiac disease (NYHA class 3 or 4)

Where it's running

  • Cairo University Hospitals
    Cairo, Egypt     Recruiting

Study contacts

  • Principal investigator: Nazmy S Mikhael, M.D. — Kasr Al-Ainy Hospital, Faculty of Medicine, Cairo University
  • Study coordinator: Mohamed M Mohamed, M.Sc.
  • Email: mandamembo0@gmail.com
  • Phone: +20 111 8370641

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
View on ClinicalTrials.gov ↗ Find more trials like this →
Browse more
Prostate Cancer 1464Fluid Overload 11Cairo University 349
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.